Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.60 (¥4,201)+6.81%▲ (in JPY terms)
SoftBank|$25.42 (¥4,014)-5.97%▼ (in JPY terms)
MUFG|$22.01 (¥3,475)+3.42%▲ (in JPY terms)
Keyence|$461.92 (¥72,940)-3.42%▼ (in JPY terms)
Nintendo|$55.60 (¥8,780)+5.11%▲ (in JPY terms)
NTT|$1.05 (¥166)+1.16%▲ (in JPY terms)
Takeda|$43.79 (¥6,915)+4.96%▲ (in JPY terms)
Tokyo Electron|$55.60 (¥8,780)-9.14%▼ (in JPY terms)
Recruit|$114.91 (¥18,145)+3.39%▲ (in JPY terms)
ITOCHU|$15.26 (¥2,409)+6.08%▲ (in JPY terms)
Honda|$12.11 (¥1,913)+6.40%▲ (in JPY terms)
Shin-Etsu|$35.84 (¥5,659)-2.41%▼ (in JPY terms)
Tokio Marine|$3.86 (¥610)+5.44%▲ (in JPY terms)
Fast Retailing|$514.16 (¥81,190)+4.94%▲ (in JPY terms)
Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.60 (¥4,201)+6.81%▲ (in JPY terms)
SoftBank|$25.42 (¥4,014)-5.97%▼ (in JPY terms)
MUFG|$22.01 (¥3,475)+3.42%▲ (in JPY terms)
Keyence|$461.92 (¥72,940)-3.42%▼ (in JPY terms)
Nintendo|$55.60 (¥8,780)+5.11%▲ (in JPY terms)
NTT|$1.05 (¥166)+1.16%▲ (in JPY terms)
Takeda|$43.79 (¥6,915)+4.96%▲ (in JPY terms)
Tokyo Electron|$55.60 (¥8,780)-9.14%▼ (in JPY terms)
Recruit|$114.91 (¥18,145)+3.39%▲ (in JPY terms)
ITOCHU|$15.26 (¥2,409)+6.08%▲ (in JPY terms)
Honda|$12.11 (¥1,913)+6.40%▲ (in JPY terms)
Shin-Etsu|$35.84 (¥5,659)-2.41%▼ (in JPY terms)
Tokio Marine|$3.86 (¥610)+5.44%▲ (in JPY terms)
Fast Retailing|$514.16 (¥81,190)+4.94%▲ (in JPY terms)

2026-03-02 Astellas Pharma Inc. “Results from the Phase III EV-304 trial of the antibody-drug conjugate PADCEV™ (enfortumab vedotin) in cisplatin-eligible muscle-invasive bladder cancer were presented at the 2026 American Society of Clinical Oncology (ASCO GU) Annual Meeting.”

2026-03-02 Astellas Pharma Inc. “Results from the Phase III EV-304 trial of the antibody-drug conjugate … 続きを読む